$CYTR marketscreener.com/quote/st... what a travesty that K took such a singular approach, (aldox), when the drug delivery platform approval would have transformed cytotoxic chemo delivery to cancer patients... but K was always Soon's puppet, his wind-up doll, from the very beginning... keeping Abraxane safe and making sure that aldox/ drug delivery platform ends up with Soon. certainly Soon will make K out to be the laughing stock of bio- CEO's for not constructing different chemo's for the sake of safer patient cancer care, making the delivery system the SOC for cytotxic drug delivery... imo